• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
-
 
Approval Date:  07/23/2009
 
Trade Name:  Actonel
 
Generic or Proper Name (*):  risedronate
 
Indications Studied:  Osteogenesis imperfecta
 
Therapeutic Category:  Bone density
 
Ages Studied:  4-<16 years
 
Study #:  1
 
Study Type:  Safety/Pharmacokinetic/Tolerability
 
Study Design:  Open Label/Traditional Pharmacokinetic
 
No Patients:  28
 
No Centers:  1
 
No Countries:  1
 
BPCA(B), PREA(P):  B
 
Asian:  2
 
-
-